Antibody-guided drug works against acute lymphoblastic leukemia
Monday, May 23, 2011 - 15:31
in Health & Medicine
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.